은 함유 창상 피복재 시장 : 제품 유형별, 치료법별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2021-2031년)

The global silver wound dressings market was valued at $889.1 million in 2021, and is projected to reach $1,511.8 million by 2031, registering a CAGR of 5.4% from 2022 to 2031.Silver wound dressings are antimicrobial dressings, which are integrated with silver. The metal, in ionized form, exhibits enhanced antifungal and antimicrobial properties, and are used in wound dressings for preventing biofilm formation by pathogenic bacteria These dressings are wound care products intended to manage bioburden in acute and chronic wounds. In addition, these dressings provide antimicrobial action on low to high exudates wounds, ulcers, and burns.

The key factors that drive the growth of the market are increase in prevalence of sport related injuries and & road accidents, rise in geriatric population, and surge in number of surgical procedures. For instance, according to International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Furthermore, it was estimated that more than 1.2 million children and adolescents (0-19 years) are living with type 1 diabetes and 541 million adults are at increased risk of developing type 2 diabetes.

Moreover, the rise in awareness of the beneficial properties of silver incorporated dressing such as antimicrobial nature, reduction in healing time and lowered infection risks are the key factors boost the growth of the market.

However, the high cost of silver wound care is expected to hinder the growth of the market. On the other hand, rise in geriatric population, increasing awareness towards advanced wound care therapies and high growth optional in developing economies are anticipated to provide lucrative opportunities for the growth of the market during the forecast period. 

The silver wound dressings market is segmented on the basis of product type, treatment, end user, and region. By product type, it is categorized into sheets, gel & creams, foams, and others. The gels & creams segment is further classified into alginate, hydrogel, silver sulfadiazine and others. By treatment, the market is categorized into ulcers, skin grafts, lacerations & cuts, surgical wounds, burns, and others. By end user, the market is fragmented into hospital & clinics, ambulatory surgical centers, and homecare. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the silver wound dressings market share in 2021 and is anticipated to remain dominant during the forecast period. The market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of diabetes and chronic & acute wounds. Moreover, the presence of a number of key players involved in R&D activities for the development of technologically advanced products is contributing toward the market growth in this region.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of large geriatric population and constantly improving healthcare infrastructure. In addition, the rapidly growing population, and increase in number of surgical procedures and road accidents, is set to drive the market growth in the Asia-Pacific region.

The key players that operate in the silver wound dressings market include 3M (Acelity Inc.), Medline Industries, LP, Argentum Medical LLC, B. Braun Melsungen AG, Convatec Inc, Dermarite Industries, Inc, Ferris Mfg. Corp., Ltd., Johnson and Johnson, Molnlycke Health Care AB, and Smith and Nephew PLC.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the silver wound dressings market analysis from 2021 to 2031 to identify the prevailing silver wound dressings market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the silver wound dressings market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global silver wound dressings market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

• Sheets
• Gels and Creams
  • Type
  • Alginate
  • Hydrogel
  • Silver sulfadiazine
  • Others
• Foams
• Others

By Treatment

• Surgical Wounds
• Burns
• Ulcers
• Lacerations and Cuts
• Skin Grafts
• Others

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Homecare

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
• Key Market Players
  • 3M Company
  • Argentum Medical LLC
  • , B Braun Melsungen AG
  • Convatec, Inc.
  • Ferris Mfg.Corp
  • Johnson And Johnson
  • Monlycke Health Care
  • Molnlycke Health Care
  • medline industries, inc.
  • DermaRite Industries, LLC.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Sheets
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market share analysis by country
• 4.3 Gels and Creams
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market share analysis by country
  • 4.3.4 Gels and Creams Silver Wound Dressings Market by Type
• 4.4 Foams
  • 4.4.1 Key market trends, growth factors and opportunities
  • 4.4.2 Market size and forecast, by region
  • 4.4.3 Market share analysis by country
• 4.5 Others
  • 4.5.1 Key market trends, growth factors and opportunities
  • 4.5.2 Market size and forecast, by region
  • 4.5.3 Market share analysis by country

CHAPTER 5: SILVER WOUND DRESSINGS MARKET, BY TREATMENT

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Surgical Wounds
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market share analysis by country
• 5.3 Burns
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market share analysis by country
• 5.4 Ulcers
  • 5.4.1 Key market trends, growth factors and opportunities
  • 5.4.2 Market size and forecast, by region
  • 5.4.3 Market share analysis by country
• 5.5 Lacerations and Cuts
  • 5.5.1 Key market trends, growth factors and opportunities
  • 5.5.2 Market size and forecast, by region
  • 5.5.3 Market share analysis by country
• 5.6 Skin Grafts
  • 5.6.1 Key market trends, growth factors and opportunities
  • 5.6.2 Market size and forecast, by region
  • 5.6.3 Market share analysis by country
• 5.7 Others
  • 5.7.1 Key market trends, growth factors and opportunities
  • 5.7.2 Market size and forecast, by region
  • 5.7.3 Market share analysis by country

CHAPTER 6: SILVER WOUND DRESSINGS MARKET, BY END USER

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Hospitals and Clinics
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market share analysis by country
• 6.3 Ambulatory Surgical Centers
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market share analysis by country
• 6.4 Homecare
  • 6.4.1 Key market trends, growth factors and opportunities
  • 6.4.2 Market size and forecast, by region
  • 6.4.3 Market share analysis by country

CHAPTER 7: SILVER WOUND DRESSINGS MARKET, BY REGION

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 North America
  • 7.2.1 Key trends and opportunities
  • 7.2.2 North America Market size and forecast, by Product Type
  • 7.2.3 North America Market size and forecast, by Treatment
  • 7.2.4 North America Market size and forecast, by End User
  • 7.2.5 North America Market size and forecast, by country
    • 7.2.5.1 U.S.
    • 7.2.5.1.1 Key market trends, growth factors and opportunities
    • 7.2.5.1.2 Market size and forecast, by Product Type
    • 7.2.5.1.3 Market size and forecast, by Treatment
    • 7.2.5.1.4 Market size and forecast, by End User
    • 7.2.5.2 Canada
    • 7.2.5.2.1 Key market trends, growth factors and opportunities
    • 7.2.5.2.2 Market size and forecast, by Product Type
    • 7.2.5.2.3 Market size and forecast, by Treatment
    • 7.2.5.2.4 Market size and forecast, by End User
    • 7.2.5.3 Mexico
    • 7.2.5.3.1 Key market trends, growth factors and opportunities
    • 7.2.5.3.2 Market size and forecast, by Product Type
    • 7.2.5.3.3 Market size and forecast, by Treatment
    • 7.2.5.3.4 Market size and forecast, by End User
• 7.3 Europe
  • 7.3.1 Key trends and opportunities
  • 7.3.2 Europe Market size and forecast, by Product Type
  • 7.3.3 Europe Market size and forecast, by Treatment
  • 7.3.4 Europe Market size and forecast, by End User
  • 7.3.5 Europe Market size and forecast, by country
    • 7.3.5.1 Germany
    • 7.3.5.1.1 Key market trends, growth factors and opportunities
    • 7.3.5.1.2 Market size and forecast, by Product Type
    • 7.3.5.1.3 Market size and forecast, by Treatment
    • 7.3.5.1.4 Market size and forecast, by End User
    • 7.3.5.2 France
    • 7.3.5.2.1 Key market trends, growth factors and opportunities
    • 7.3.5.2.2 Market size and forecast, by Product Type
    • 7.3.5.2.3 Market size and forecast, by Treatment
    • 7.3.5.2.4 Market size and forecast, by End User
    • 7.3.5.3 UK
    • 7.3.5.3.1 Key market trends, growth factors and opportunities
    • 7.3.5.3.2 Market size and forecast, by Product Type
    • 7.3.5.3.3 Market size and forecast, by Treatment
    • 7.3.5.3.4 Market size and forecast, by End User
    • 7.3.5.4 Italy
    • 7.3.5.4.1 Key market trends, growth factors and opportunities
    • 7.3.5.4.2 Market size and forecast, by Product Type
    • 7.3.5.4.3 Market size and forecast, by Treatment
    • 7.3.5.4.4 Market size and forecast, by End User
    • 7.3.5.5 Spain
    • 7.3.5.5.1 Key market trends, growth factors and opportunities
    • 7.3.5.5.2 Market size and forecast, by Product Type
    • 7.3.5.5.3 Market size and forecast, by Treatment
    • 7.3.5.5.4 Market size and forecast, by End User
    • 7.3.5.6 Rest of Europe
    • 7.3.5.6.1 Key market trends, growth factors and opportunities
    • 7.3.5.6.2 Market size and forecast, by Product Type
    • 7.3.5.6.3 Market size and forecast, by Treatment
    • 7.3.5.6.4 Market size and forecast, by End User
• 7.4 Asia-Pacific
  • 7.4.1 Key trends and opportunities
  • 7.4.2 Asia-Pacific Market size and forecast, by Product Type
  • 7.4.3 Asia-Pacific Market size and forecast, by Treatment
  • 7.4.4 Asia-Pacific Market size and forecast, by End User
  • 7.4.5 Asia-Pacific Market size and forecast, by country
    • 7.4.5.1 Japan
    • 7.4.5.1.1 Key market trends, growth factors and opportunities
    • 7.4.5.1.2 Market size and forecast, by Product Type
    • 7.4.5.1.3 Market size and forecast, by Treatment
    • 7.4.5.1.4 Market size and forecast, by End User
    • 7.4.5.2 China
    • 7.4.5.2.1 Key market trends, growth factors and opportunities
    • 7.4.5.2.2 Market size and forecast, by Product Type
    • 7.4.5.2.3 Market size and forecast, by Treatment
    • 7.4.5.2.4 Market size and forecast, by End User
    • 7.4.5.3 Australia
    • 7.4.5.3.1 Key market trends, growth factors and opportunities
    • 7.4.5.3.2 Market size and forecast, by Product Type
    • 7.4.5.3.3 Market size and forecast, by Treatment
    • 7.4.5.3.4 Market size and forecast, by End User
    • 7.4.5.4 India
    • 7.4.5.4.1 Key market trends, growth factors and opportunities
    • 7.4.5.4.2 Market size and forecast, by Product Type
    • 7.4.5.4.3 Market size and forecast, by Treatment
    • 7.4.5.4.4 Market size and forecast, by End User
    • 7.4.5.5 South Korea
    • 7.4.5.5.1 Key market trends, growth factors and opportunities
    • 7.4.5.5.2 Market size and forecast, by Product Type
    • 7.4.5.5.3 Market size and forecast, by Treatment
    • 7.4.5.5.4 Market size and forecast, by End User
    • 7.4.5.6 Rest of Asia-Pacific
    • 7.4.5.6.1 Key market trends, growth factors and opportunities
    • 7.4.5.6.2 Market size and forecast, by Product Type
    • 7.4.5.6.3 Market size and forecast, by Treatment
    • 7.4.5.6.4 Market size and forecast, by End User
• 7.5 LAMEA
  • 7.5.1 Key trends and opportunities
  • 7.5.2 LAMEA Market size and forecast, by Product Type
  • 7.5.3 LAMEA Market size and forecast, by Treatment
  • 7.5.4 LAMEA Market size and forecast, by End User
  • 7.5.5 LAMEA Market size and forecast, by country
    • 7.5.5.1 Brazil
    • 7.5.5.1.1 Key market trends, growth factors and opportunities
    • 7.5.5.1.2 Market size and forecast, by Product Type
    • 7.5.5.1.3 Market size and forecast, by Treatment
    • 7.5.5.1.4 Market size and forecast, by End User
    • 7.5.5.2 Saudi Arabia
    • 7.5.5.2.1 Key market trends, growth factors and opportunities
    • 7.5.5.2.2 Market size and forecast, by Product Type
    • 7.5.5.2.3 Market size and forecast, by Treatment
    • 7.5.5.2.4 Market size and forecast, by End User
    • 7.5.5.3 South Africa
    • 7.5.5.3.1 Key market trends, growth factors and opportunities
    • 7.5.5.3.2 Market size and forecast, by Product Type
    • 7.5.5.3.3 Market size and forecast, by Treatment
    • 7.5.5.3.4 Market size and forecast, by End User
    • 7.5.5.4 Rest of LAMEA
    • 7.5.5.4.1 Key market trends, growth factors and opportunities
    • 7.5.5.4.2 Market size and forecast, by Product Type
    • 7.5.5.4.3 Market size and forecast, by Treatment
    • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

• 9.1 3M Company
  • 9.1.1 Company overview
  • 9.1.2 Company snapshot
  • 9.1.3 Operating business segments
  • 9.1.4 Product portfolio
  • 9.1.5 Business performance
  • 9.1.6 Key strategic moves and developments
• 9.2 Argentum Medical LLC
  • 9.2.1 Company overview
  • 9.2.2 Company snapshot
  • 9.2.3 Operating business segments
  • 9.2.4 Product portfolio
  • 9.2.5 Business performance
  • 9.2.6 Key strategic moves and developments
• 9.3 , B Braun Melsungen AG
  • 9.3.1 Company overview
  • 9.3.2 Company snapshot
  • 9.3.3 Operating business segments
  • 9.3.4 Product portfolio
  • 9.3.5 Business performance
  • 9.3.6 Key strategic moves and developments
• 9.4 Convatec, Inc.
  • 9.4.1 Company overview
  • 9.4.2 Company snapshot
  • 9.4.3 Operating business segments
  • 9.4.4 Product portfolio
  • 9.4.5 Business performance
  • 9.4.6 Key strategic moves and developments
• 9.5 Ferris Mfg.Corp
  • 9.5.1 Company overview
  • 9.5.2 Company snapshot
  • 9.5.3 Operating business segments
  • 9.5.4 Product portfolio
  • 9.5.5 Business performance
  • 9.5.6 Key strategic moves and developments
• 9.6 Johnson And Johnson
  • 9.6.1 Company overview
  • 9.6.2 Company snapshot
  • 9.6.3 Operating business segments
  • 9.6.4 Product portfolio
  • 9.6.5 Business performance
  • 9.6.6 Key strategic moves and developments
• 9.7 Monlycke Health Care
  • 9.7.1 Company overview
  • 9.7.2 Company snapshot
  • 9.7.3 Operating business segments
  • 9.7.4 Product portfolio
  • 9.7.5 Business performance
  • 9.7.6 Key strategic moves and developments
• 9.8 Molnlycke Health Care
  • 9.8.1 Company overview
  • 9.8.2 Company snapshot
  • 9.8.3 Operating business segments
  • 9.8.4 Product portfolio
  • 9.8.5 Business performance
  • 9.8.6 Key strategic moves and developments
• 9.9 medline industries, inc.
  • 9.9.1 Company overview
  • 9.9.2 Company snapshot
  • 9.9.3 Operating business segments
  • 9.9.4 Product portfolio
  • 9.9.5 Business performance
  • 9.9.6 Key strategic moves and developments
• 9.10 DermaRite Industries, LLC.
  • 9.10.1 Company overview
  • 9.10.2 Company snapshot
  • 9.10.3 Operating business segments
  • 9.10.4 Product portfolio
  • 9.10.5 Business performance
  • 9.10.6 Key strategic moves and developments